Bilirubin: A Promising Therapy for Parkinson’s Disease

Following the increase in life expectancy, the prevalence of Parkinson’s disease (PD) as the most common movement disorder is expected to rise. Despite the incredibly huge efforts in research to find the definitive biomarker, to date, the diagnosis of PD still relies mainly upon clinical symptoms. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Jayanti, Sri, Moretti, Rita, Tiribelli, Claudio, Gazzin, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228391/
https://www.ncbi.nlm.nih.gov/pubmed/34207581
http://dx.doi.org/10.3390/ijms22126223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228391/
https://www.ncbi.nlm.nih.gov/pubmed/34207581
http://dx.doi.org/10.3390/ijms22126223

Ejemplares similares